Personalis, Inc.
Status: Publicly traded
Direct answer
Personalis, Inc. is publicly traded on NASDAQ under the ticker PSNL.
Personalis, Inc. operates globally as a specialized cancer genomics firm. The company delivers advanced sequencing and data analysis capabilities, primarily supporting the development of novel cancer treatments and facilitating extensive genetic research initiatives. Central to their offerings is the NeXT Platform, which enables detailed data analysis of tumors and their surrounding immune microenvironments, even...
Can you invest in Personalis, Inc.?
Yes. Personalis, Inc. is publicly traded on NASDAQ under the ticker PSNL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Personalis, Inc.
Detailed equity research is provided by MarketSnap.